
Trump's Proposed Tariffs on Generic Drugs Spark Concerns Over U.S. Production Shift
President Trump proposed tariffs up to 200% on imported generic medicines after a two-year grace period, aiming to boost U.S. production. The generic drug industry, operating on thin margins, warns that shifting manufacturing domestically within the timeframe is challenging and could lead to market exits or price increases, impacting patient access to affordable medicines.















